ATM missense mutations are frequent inpatients with breast cancer
- 1 September 2003
- journal article
- Published by Elsevier BV in Cancer Genetics and Cytogenetics
- Vol. 145 (2), 115-120
- https://doi.org/10.1016/s0165-4608(03)00119-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controlsCancer Genetics and Cytogenetics, 2002
- Dominant Negative ATM Mutations in Breast Cancer FamiliesJNCI Journal of the National Cancer Institute, 2002
- Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancerProceedings of the National Academy of Sciences of the United States of America, 2002
- Recent trends in breast cancer incidence and mortalityEnvironmental and Molecular Mutagenesis, 2002
- Breast cancer genetics: What we know and what we needNature Medicine, 2001
- ATM Mutations and Phenotypes in Ataxia-Telangiectasia Families in the British Isles: Expression of Mutant ATM and the Risk of Leukemia, Lymphoma, and Breast CancerAmerican Journal of Human Genetics, 1998
- Heterozygous ATM mutations do not contribute to early onset of breast cancerNature Genetics, 1997
- Diversity ofATM gene mutations detected in patients with ataxia-telangiectasiaHuman Mutation, 1997
- A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 KinaseScience, 1995
- Incidence of Cancer in 161 Families Affected by Ataxia–TelangiectasiaNew England Journal of Medicine, 1991